StrideBio
Acquired- Total Funding
- $15.7M
- Last Round
- $15.7M Series AJun 2018
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Developing engineered viral vectors for gene therapy.
Summary
StrideBio is a Biotech company. It has raised $15.7M in total across 1 round, most recently a $15.7M Series A round in Jun 2018. Investors include Takeda (US) and UCB.
Funding History
Jun 2018
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/stridebio"><img src="https://indexed.vc/api/badge/company/stridebio" alt="StrideBio on Indexed.vc" width="260" height="76" /></a>